Resitu: minimally invasive surgical technology


Resitu Medical is developing instruments for safe removal of large intact tissue samples. Our first product in development is intended for sampling of breast tissue during a breast biopsy procedure.

The minimally invasive single-use, ultrasound guided device uses diathermy to extract tissue samples with minimal bleeding. It aims to extract the complete lesion without open surgery to provide optimal samples for histopathological examination, reducing the risk for ambiguous tissue analysis or incorrect result.

Guided by ultrasound, the doctor places the tip of the instrument at the site of the lesion. Simply pulling back the handle creates a vacuum that allows the entire lesion to enter the tube.

The instrument is pushed gently into the breast and the diathermic electrode is pushed forward with the slider on the handle. Rotating the handle severs the lesion from the surrounding area and the intact lesion is sent to histopathology for analysis.

View full movie

This revolutionary technology has potential to create a paradigm shift in breast cancer management, by shortening the process and ultimately fuse the diagnostic procedure with the removal of an intact lesion. That way, we could avoid overtreatment, enhance patient experience and mitigate burden for the healthcare system.


Resitu Medical AB
Rapsgatan 7B
Uppsala, Sweden

Resitu Medical AB is a Swedish Medical Device company founded in 2019. The company is developing instruments enabling safe removal of intact tissues by a revolutionary technology. The solution has the potential to create a paradigm shift in the management of breast cancer. The portfolio of instruments will speed up the process of cancer management using a minimally invasive approach and facilitating the way radiologists and surgeons work.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.